Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06379399
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2024-04-18
Brief Title:
TrifluridineTipiracil Combined With Cetuximab in the Treatment of Third-line and Above RASBRAF Wild-type mCRC
Sponsor:
Wangxia LV
Organization:
Zhejiang Cancer Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Colorectal Cancer Metastatic |
Keywords:
| Name | View |
|---|---|
| RASBRAF wild-type | View |